Vanda Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Vanda Pharmaceuticals Inc cash flow-to-debt ratio. Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow-to-Debt Ratio of -0.18x as of December 2025, meaning its operating cash flow of $-29.42 Million could theoretically repay 0% of its total liabilities ($161.76 Million) in one year. Check cash flow quality index of Vanda Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Vanda Pharmaceuticals Inc (2004–2025)
Cash flow-to-debt ratio of Vanda Pharmaceuticals Inc from 2004 to 2025. Historical debt coverage capacity for Vanda Pharmaceuticals Inc across 22 annual periods. Check total reinvestment intensity of Vanda Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Vanda Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2004–2025)
Vanda Pharmaceuticals Inc cash flow-to-debt ratio by year from 2004 to 2025. Year-by-year debt coverage analysis for Vanda Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Vanda Pharmaceuticals Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.68x | $-109.44 Million | $161.76 Million | ▼ -405.2% |
| 2024 | -0.13x | $-15.76 Million | $117.66 Million | ▼ -208.3% |
| 2023 | 0.12x | $12.80 Million | $103.53 Million | ▼ -58.6% |
| 2022 | 0.30x | $31.98 Million | $107.05 Million | ▼ -58.7% |
| 2021 | 0.72x | $64.21 Million | $88.86 Million | ▲ +11.9% |
| 2020 | 0.65x | $51.77 Million | $80.19 Million | ▲ +2.3% |
| 2019 | 0.63x | $45.95 Million | $72.80 Million | ▲ +19.4% |
| 2018 | 0.53x | $29.99 Million | $56.71 Million | ▲ +2074.3% |
| 2017 | -0.03x | $-1.98 Million | $74.04 Million | ▲ +73.9% |
| 2016 | -0.10x | $-8.10 Million | $79.04 Million | ▼ -165.9% |
| 2015 | 0.16x | $12.45 Million | $80.02 Million | ▲ +102.1% |
| 2014 | -7.49x | $-81.55 Million | $10.89 Million | ▼ -1777.4% |
| 2013 | -0.40x | $-39.59 Million | $99.22 Million | ▼ -11.5% |
| 2012 | -0.36x | $-44.92 Million | $125.54 Million | ▼ -87.8% |
| 2011 | -0.19x | $-28.41 Million | $149.14 Million | ▼ -206.5% |
| 2010 | -0.06x | $-10.90 Million | $175.37 Million | ▼ -107.4% |
| 2009 | 0.84x | $169.34 Million | $202.68 Million | ▲ +107.1% |
| 2008 | -11.74x | $-45.96 Million | $3.91 Million | ▼ -198.6% |
| 2007 | -3.93x | $-51.64 Million | $13.13 Million | ▲ +27.6% |
| 2006 | -5.43x | $-51.62 Million | $9.50 Million | ▼ -56.0% |
| 2005 | -3.48x | $-17.71 Million | $5.09 Million | ▲ +26.9% |
| 2004 | -4.76x | $-8.61 Million | $1.81 Million | — |